Related content

Effects of atypical antipsychotics on the inflammatory response system in schizophrenic patients resistant to treatment with typical neuroleptics

By Maes M.   Bocchio Chiavetto L.   Bignotti S.   Battisa Tura G.-J.   Pioli R.   Boin F.   Kenis G.   Bosmans E.   de Jongh R.   Lin A.   Racagni G.   Altamura C.A.  

European Neuropsychopharmacology, Vol. 10, Iss. 2, 2000-03 ,pp. : 119-124

Elsevier

Access to resources Recommend Favorite

Clozapine antagonizes the induction of striatal Fos expression by typical neuroleptics

By Wirtshafter D.  

European Journal of Pharmacology, Vol. 358, Iss. 3, 1998-10 ,pp. : 1-3

Elsevier

Access to resources Recommend Favorite

Cannabis Using Schizophrenia Patients Treated with Atypical Neuroleptics: Do Their Symptoms Differ from Those of Cannabis Abstainers?

By Schaub Michael   Fanghaenel Kyra   Senn Charlotte   Stohler Rudolf  

Substance Use & Misuse, Vol. 43, Iss. 14, 2008-12 ,pp. : 2045-2052

Informa Healthcare

Access to resources Recommend Favorite

Ethical and Legal Problems in Treating Schizophrenic Patients with Neuroleptics During Childhood and Adolescence

By  

Child and Adolescent Psychopharmacology News, Vol. 8, Iss. 4, 2003-06 ,pp. : 5-9

Guilford Publications Inc

Access to resources Recommend Favorite

Striatal dopamine-2 receptor occupancy as measured with [I]iodobenzamide and SPECT predicted the occurrence of EPS in patients treated with atypical antipsychotics and haloperidol

By Tauscher Johannes   Küfferle Bernd   Asenbaum Susanne   Tauscher-Wisniewski Sitra   Kasper Siegfried  

Psychopharmacology, Vol. 162, Iss. 1, 2002-06 ,pp. : 42-49

Springer Publishing Company

Access to resources Recommend Favorite